Skip to main content
Clinical Trials/ISRCTN52227045
ISRCTN52227045Active, not recruitingUnknown

A comprehensive life-style and multi-omics integrative approach to study metabolic processes related to cognitive function, cognitive decline and progression to dementia

Institut d'Investigació Sanitària Pere Virgili0 sites300 target enrollmentStarted: May 16, 2023Last updated:

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Men and women aged between 45-80 years old
  • 2. Mini-Mental State Examination (MMSE) = 26, hospital anxiety scale = , hospital depression scale = 11

Exclusion Criteria

  • 1. Mini-Mental State Examination (MMSE) <26 or inability to give informed consent
  • 2. Diagnosis of dementia
  • 3. Presence of depressive symptoms (Geriatric Depression Scale =5)
  • 4. Major medical or psychiatric condition
  • 5. Evidence of impairment due to psychoactive drugs
  • 6. Alcohol or drug abuse
  • 7. Inability to perform imaging studies (i.e.CAT, MR)
  • 8. Other conditions under the neurologist criteria

Investigators

Sponsor
Institut d'Investigació Sanitària Pere Virgili

Similar Trials